Pharmacokinetic Study of Aprepitant in BEP Treatment of Patients With Testis Carcinoma (A-BEP)
This study has been terminated.
(change of study population and chemotherapeutic regimen)
Merck Sharp & Dohme Corp.
Information provided by:
First received: January 31, 2007
Last updated: May 20, 2008
Last verified: May 2008
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Estimated Study Completion Date:||September 2008|
|Estimated Primary Completion Date:||No date given|